Partnering Opportunities

Response Biomedical has developed blue chip partnerships with Roche Diagnostics, for our cardiovascular line of products, 3M Health Care for infectious diseases and Shionogi and Company Ltd. in Japan, where our BNP Test is marketed.
 
The Company also recently announced a new collaboration/grant with FIND, (Foundation for Innovative New Diagnostics) to begin work to develop a rapid point-of-care (POC) tuberculosis (TB) diagnostic assay. FIND is a Swiss non-profit independent organization whose donors include the Bill & Melinda Gates Foundation, the European Union, and the Government of the Netherlands.
 
We are also interested in developing new collaborations as we build the business. Opportunities we would be interested in exploring include oncology, coagulation, obstetrics and renal failure and other areas where our novel technology platform may be of benefit.
 
Enquiries should be directed to the Company's Business Development Officer.